Dyspnea

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Dyspnea, also called air hunger or shortness of breath, is a symptom of ME/CFS.

Prevalence[edit | edit source]

  • 1995, Katrina Berne, PhD, reported a prevalence of 30-70% for shortness of breath.[1]
  • 2001, In a Belgian study, 79.2% of patients meeting the Fukuda criteria and 83.5% of patients meeting the Holmes criteria, in a cohort of 2073 CFS patients, reported exertional dyspnea.[2]

Symptom recognition[edit | edit source]

  • Air hunger or labored breathing are also included in the criteria for diagnosis in the International Consensus Criteria, under Respiratory part of Energy production/transportation impairments.[4]

Shortness of breath is a potential symptom of Long COVID in the World Health Organization's definition.[6]

Notable studies[edit | edit source]

  • 2012, Dyspnea in Chronic Fatigue Syndrome (CFS): Comparison of Two Prospective Cross-Sectional Studies.[7] - (Full Text)

Possible causes[edit | edit source]

Potential treatments[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. Berne, Katrina (December 1, 1995). Running on Empty: The Complete Guide to Chronic Fatigue Syndrome (CFIDS) (2nd ed.). Hunter House. p. 58. ISBN 978-0897931915.
  2. De Becker, Pascale; McGregor, Neil; De Meirleir, Kenny (December 2001). "A definition‐based analysis of symptoms in a large cohort of patients with chronic fatigue syndrome". Journal of Internal Medicine. 250 (3): 234–240. doi:10.1046/j.1365-2796.2001.00890.x.
  3. A Clinical Case Definition and Guidelines for Medical Practitioners: An Overview of the Canadian Consensus Document
  4. Carruthers, BM; van de Sande, MI; De Meirleir, KL; Klimas, NG; Broderick, G; Mitchell, T; Staines, D; Powles, ACP; Speight, N; Vallings, R; Bateman, L; Baumgarten-Austrheim, B; Bell, DS; Carlo-Stella, N; Chia, J; Darragh, A; Jo, D; Lewis, DP; Light, AR; Marshall-Gradisnik, S; Mena, I; Mikovits, JA; Miwa, K; Murovska, M; Pall, ML; Stevens, SR (August 22, 2011), "Myalgic encephalomyelitis: International Consensus Criteria", Journal of Internal Medicine, 270 (4): 327–338, doi:10.1111/j.1365-2796.2011.02428.x, PMID 21777306
  5. Institute of Medicine (2015). Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington, DC: The National Academies Press. doi:10.17226/19012. ISBN 0309316898. PMID 25695122.
  6. Soriano, Joan B.; Allan, Maya; Alsokhn, Carine; Alwan, Nisreen A.; Askie, Lisa; Davis, Hannah E.; Diaz, Janet V.; Dua, Tarun; de Groote, Wouter; Jakob, Robert; Lado, Marta; Marshall, John; Murthy, Srin; Preller, Jacobus; Relan, Pryanka; Schiess, Nicoline; Seahwag, Archana (October 6, 2021), A clinical case definition of post COVID-19 condition by a Delphi consensus, World Health Organization (WHO) clinical case definition working group on post COVID-19 condition, World Health Organization
  7. Ravindran, Murugan; Adewuyi, Oluwatoyin; Zheng, Yin; Rayhan, Rakib U.; Le, Uyenphuong; Timbol, Christian; Merck, Samantha; Esteitie, Rania; Read, Charles; Baraniuk, James (December 12, 2012). "Dyspnea in Chronic Fatigue Syndrome (CFS): Comparison of Two Prospective Cross-Sectional Studies". Global Journal of Health Science. 5 (2). doi:10.5539/gjhs.v5n2p94. ISSN 1916-9744.
  8. Johnson, Miriam J.; Currow, David C. (September 1, 2020). "Opioids for breathlessness: a narrative review". BMJ Supportive & Palliative Care. 10 (3): 287–295. doi:10.1136/bmjspcare-2020-002314. ISSN 2045-435X. PMID 32620683.